A turning point in hepatology? EASL reflects on the first approved drug for MASH

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of hepatology 2024-08, Vol.81 (2), p.192-194
Hauptverfasser:	Francque, Sven, Krag, Aleksander, Shawcross, Debbie L., Zelber-Sagi, Shira
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized - therapeutic use Drug Approval Europe Gastroenterology - methods Humans
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	194
container_issue	2
container_start_page	192
container_title	Journal of hepatology
container_volume	81
creator	Francque, Sven Krag, Aleksander Shawcross, Debbie L. Zelber-Sagi, Shira
description
doi_str_mv	10.1016/j.jhep.2024.04.036
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3056664250</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168827824003404</els_id><sourcerecordid>3056664250</sourcerecordid><originalsourceid>FETCH-LOGICAL-c281t-a6896040969d79441ce9deaac70dfced29b7597fc07b010bf937bf29f0fa0ffb3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotn78AQ-So5etk-w22YAgRdQKFQX1HLLZpE3ZbtZkV_Dfm9LqURiYy_O-zDwIXRCYECDsej1Zr0w3oUCLCaTJ2QEaEwaQASvIIRonqMxKyssROolxDQA5iOIYjfKSM0o4jNHrDPdDaF27xJ13bY9di1Op6n3jl9-3-H72tsDB2MboPmLf4n5lsHUh9lh1XfBfpsZ1GJbY-oCfZ2_zM3RkVRPN-X6foo-H-_e7ebZ4eXy6my0yTUvSZ4qVgkEBgomai6Ig2ojaKKU51FabmoqKTwW3GngFBCorcl5ZKixYBdZW-Sm62vWmIz4HE3u5cVGbplGt8UOUOUwZYwWdQkLpDtXBx5iekV1wGxW-JQG5NSnXcmtSbk1KSJOzFLrc9w_VxtR_kV91CbjZASZ9-eVMkFE706bbXUiyZO3df_0_aEeEHg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3056664250</pqid></control><display><type>article</type><title>A turning point in hepatology? EASL reflects on the first approved drug for MASH</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Francque, Sven ; Krag, Aleksander ; Shawcross, Debbie L. ; Zelber-Sagi, Shira</creator><creatorcontrib>Francque, Sven ; Krag, Aleksander ; Shawcross, Debbie L. ; Zelber-Sagi, Shira</creatorcontrib><identifier>ISSN: 0168-8278</identifier><identifier>ISSN: 1600-0641</identifier><identifier>EISSN: 1600-0641</identifier><identifier>DOI: 10.1016/j.jhep.2024.04.036</identifier><identifier>PMID: 38762170</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Antibodies, Monoclonal, Humanized - therapeutic use ; Drug Approval ; Europe ; Gastroenterology - methods ; Humans</subject><ispartof>Journal of hepatology, 2024-08, Vol.81 (2), p.192-194</ispartof><rights>2024 European Association for the Study of the Liver</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c281t-a6896040969d79441ce9deaac70dfced29b7597fc07b010bf937bf29f0fa0ffb3</cites><orcidid>0000-0002-9598-4932</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jhep.2024.04.036$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38762170$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Francque, Sven</creatorcontrib><creatorcontrib>Krag, Aleksander</creatorcontrib><creatorcontrib>Shawcross, Debbie L.</creatorcontrib><creatorcontrib>Zelber-Sagi, Shira</creatorcontrib><title>A turning point in hepatology? EASL reflects on the first approved drug for MASH</title><title>Journal of hepatology</title><addtitle>J Hepatol</addtitle><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>Drug Approval</subject><subject>Europe</subject><subject>Gastroenterology - methods</subject><subject>Humans</subject><issn>0168-8278</issn><issn>1600-0641</issn><issn>1600-0641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotn78AQ-So5etk-w22YAgRdQKFQX1HLLZpE3ZbtZkV_Dfm9LqURiYy_O-zDwIXRCYECDsej1Zr0w3oUCLCaTJ2QEaEwaQASvIIRonqMxKyssROolxDQA5iOIYjfKSM0o4jNHrDPdDaF27xJ13bY9di1Op6n3jl9-3-H72tsDB2MboPmLf4n5lsHUh9lh1XfBfpsZ1GJbY-oCfZ2_zM3RkVRPN-X6foo-H-_e7ebZ4eXy6my0yTUvSZ4qVgkEBgomai6Ig2ojaKKU51FabmoqKTwW3GngFBCorcl5ZKixYBdZW-Sm62vWmIz4HE3u5cVGbplGt8UOUOUwZYwWdQkLpDtXBx5iekV1wGxW-JQG5NSnXcmtSbk1KSJOzFLrc9w_VxtR_kV91CbjZASZ9-eVMkFE706bbXUiyZO3df_0_aEeEHg</recordid><startdate>202408</startdate><enddate>202408</enddate><creator>Francque, Sven</creator><creator>Krag, Aleksander</creator><creator>Shawcross, Debbie L.</creator><creator>Zelber-Sagi, Shira</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9598-4932</orcidid></search><sort><creationdate>202408</creationdate><title>A turning point in hepatology? EASL reflects on the first approved drug for MASH</title><author>Francque, Sven ; Krag, Aleksander ; Shawcross, Debbie L. ; Zelber-Sagi, Shira</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c281t-a6896040969d79441ce9deaac70dfced29b7597fc07b010bf937bf29f0fa0ffb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>Drug Approval</topic><topic>Europe</topic><topic>Gastroenterology - methods</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Francque, Sven</creatorcontrib><creatorcontrib>Krag, Aleksander</creatorcontrib><creatorcontrib>Shawcross, Debbie L.</creatorcontrib><creatorcontrib>Zelber-Sagi, Shira</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Francque, Sven</au><au>Krag, Aleksander</au><au>Shawcross, Debbie L.</au><au>Zelber-Sagi, Shira</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A turning point in hepatology? EASL reflects on the first approved drug for MASH</atitle><jtitle>Journal of hepatology</jtitle><addtitle>J Hepatol</addtitle><date>2024-08</date><risdate>2024</risdate><volume>81</volume><issue>2</issue><spage>192</spage><epage>194</epage><pages>192-194</pages><issn>0168-8278</issn><issn>1600-0641</issn><eissn>1600-0641</eissn><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>38762170</pmid><doi>10.1016/j.jhep.2024.04.036</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-9598-4932</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0168-8278
ispartof	Journal of hepatology, 2024-08, Vol.81 (2), p.192-194
issn	0168-8278 1600-0641 1600-0641
language	eng
recordid	cdi_proquest_miscellaneous_3056664250
source	MEDLINE; Access via ScienceDirect (Elsevier)
subjects	Antibodies, Monoclonal, Humanized - therapeutic use Drug Approval Europe Gastroenterology - methods Humans
title	A turning point in hepatology? EASL reflects on the first approved drug for MASH
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T01%3A08%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20turning%20point%20in%20hepatology?%20EASL%20reflects%20on%20the%20first%20approved%20drug%20for%20MASH&rft.jtitle=Journal%20of%20hepatology&rft.au=Francque,%20Sven&rft.date=2024-08&rft.volume=81&rft.issue=2&rft.spage=192&rft.epage=194&rft.pages=192-194&rft.issn=0168-8278&rft.eissn=1600-0641&rft_id=info:doi/10.1016/j.jhep.2024.04.036&rft_dat=%3Cproquest_cross%3E3056664250%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3056664250&rft_id=info:pmid/38762170&rft_els_id=S0168827824003404&rfr_iscdi=true